Curi Bio

Seattle, WA · Founded 2015 · Privately Held (backing)

Developer of a human stem cell-based platform designed to facilitate the discovery of medicines by integrating human cells, systems, and data. Curi Bio is based in Seattle, WA and was founded in 2015. Its last reported valuation was $62 million in Dec 2025. It has raised $20.1 million.

Last reported valuation
$62.0M
Oct 2026
Priced at
—
Total raised
$20.1M
Last round
—

Who backs Curi Bio?

13 investors
InvestorType
National Institutes of HealthOther
UTC InvestmentAsset manager
Double CapitalVenture capital
DS Asset Management—
Dream CIS—
Dynamk Capital—
Lung—
National Center For Advancing Translational Sciences—
National Heart—
Seattle Angel Conference—
+ 3 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Curi Bio investors

13 investors are on record for Curi Bio, including National Institutes of Health, UTC Investment, Double Capital and DS Asset Management.

Free account
More of Curi Bio with a free account
  • ·The complete investor list: 13 names
  • ·Watch Curi Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 13 firms already write checks for companies like Curi Bio. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View